(Q37796033)

23 August 2017

title

Neural grafting in Parkinson's disease unraveling the mechanisms underlying graft-induced dyskinesia (English)

1 reference

23 August 2017

1 reference

1 reference

2

Anders Björklund

0 references

Emma L. Lane

object named as

Emma L Lane

series ordinal

1

0 references

Stephen Dunnett

object named as

Stephen B Dunnett

series ordinal

3

0 references

author name string

Christian Winkler

series ordinal

4

1 reference

23 August 2017

publication date

1 January 2010

1 reference

Progress in Brain Research

23 August 2017

published in

1 reference

23 August 2017

volume

184

1 reference

23 August 2017

page(s)

295-309

1 reference

Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

The placebo effect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Preoperative response to levodopa is the best predictor of transplant outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Dyskinesias following neural transplantation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Dopaminergic neural grafts after fifteen years: results and perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: a pharmacological and biochemical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Deep brain stimulation in Parkinson's disease following fetal nigral transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Outcomes and complications of fetal tissue transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Transplanted dopaminergic neurons develop PD pathologic changes: a second case report

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical con

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Neural transplantation cannula and microinjector system: experimental and clinical experience. Technical note

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Cell transplantation in Parkinson's disease: how can we make it work?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Serotonergic stimulation of the ventrolateral striatum induces orofacial stereotypy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

Role of dopamine in behavioral effects of serotonin microinjected into rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984015-4

7 January 2021

10.1016/S0079-6123(10)84015-4

Identifiers

DOI

1 reference

23 August 2017

1 reference